Purchase of DryLab

[garry]

Hello all DryLab users

I am about to put forward a proposal for the purchase of DryLab for my laboratory and have been instructed by senior managment that I need to provide an estimate of time savings and key performance indicators. These will be used to measure the value of the purchase over the course of the year.
It is very difficult to measure time savings with such an application without using it in practical situations

Has anyone needed to go through a similar exercise and could you please give some guidence in this area.

Any help would be appreciated.
Thanking you in advance
Garry

[AA]

Garry,

I took this off of some web site. I would suggest that if you have to go to this much justificataton for as minor a purchase as a software package, you might have some serious issues at your workplace.

Good Luck

Here are the most important arguments for using DryLab in your HPLC/GC-laboratories :

1. Save time in your HPLC/GC-Lab! Learn about the influence of parameters in just a few minutes
instead of days, and have the evaluation finished for your report and printout simultaneously.

Method-Development or Method-Optimization with DryLab can save upto 90% of your development time, thereby saving you considerable amounts of money. The methods developed in DryLab often has as little as 50% of the run time of methods developed by try and error in the lab. This offers you the possibility to double the utilization of your expensive equipment and personal. To run an HPLC/GC equipment costs inbetween 750 and 1400 US $ per day. The experimental work done in one hour in the lab, can be done in less than one minute by using the DryLab software. This time reduction is of uttermost importance to your company, since every single day that your products market introduction is delayed will cost you tenth of thousands US $.

2. By using Drylab you can save materials like columns or toxic eluents:

Eluents like Tetrahydrofuran costs up to $70,- per L and Acetonitril $40,- per L.

3. Unnecessary experiments will be avoided by implementing an intelligent systematization based on modern scientific knowledge, robust computer-modeling and simulation with DryLab:

The pharmaceutical industry uses up to 16 percent of the development cost of a new drug on the development and optimization of HPLC/GC-methods. Since the developed methods often aren't robust, after work on the methods is many times necessary, this causes the costs of HPLC/GC to raise from 16 upto 60 percent of the total development cost of the new drug.